Psychiatry and Neurology, Neurology · Dallas, TX
NPI
1053417964
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
8390 Lyndon B Johnson Fwy Ste 400
Dallas, TX, 75243
Phone (214) 750-9977
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
12,817 services
Medicare patients, 2024
100
Average age 75
Drug cost, 2024
$1.1M
1,021 prescriptions
Company payments, 2025
$3,578
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Tseng was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,126 times for 13 patients. In total Anna Tseng billed 12,817 services in 67 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,126 | 13 | $4.94 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 157 | 77 | $12.17 | $1,911 |
| 99214 Office E&M - Established | Office | 144 | 72 | $93.31 | $13K |
| 99213 Office E&M - Established | Office | 22 | 15 | $65.48 | $1,441 |
| 70551 MRI/MRA - Head and Neck | Office | 18 | 13 | $99.20 | $1,786 |
By year: 2022 $56K for 4,963 services; 2023 $53K for 4,949 services; 2024 $111K for 12,817 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna Tseng prescribed most often to Medicare patients was Gabapentin, with 132 prescriptions and refills. In total Anna Tseng wrote 1,021 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 132 | 242 | 24 | $1,786 |
| Zonisamide Generic | 55 | 132 | 13 | $954 |
| Pregabalin Generic | 36 | 66 | Under 11 | $1,307 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 32 | 53 | Under 11 | $795 |
| Escitalopram Oxalate Generic | 32 | 50 | Under 11 | $203 |
| Baclofen Generic | 31 | 65 | Under 11 | $327 |
| Donepezil Hcl Generic | 30 | 73 | Under 11 | $663 |
| Plegridy Pen Peginterferon Beta-1a | 27 | 27 | Under 11 | $230K |
| Meloxicam Generic | 24 | 24 | Under 11 | $60.8 |
| Levetiracetam Generic | 24 | 42 | Under 11 | $519 |
| Primidone Generic | 23 | 67 | Under 11 | $559 |
| Quetiapine Fumarate Generic | 22 | 44 | Under 11 | $215 |
| Duloxetine Hcl Generic | 21 | 29 | Under 11 | $390 |
| Memantine Hcl Generic | 19 | 45 | Under 11 | $1,661 |
| Lamotrigine Generic | 19 | 49 | Under 11 | $1,049 |
Brand drugs: 166 claims; generic drugs: 855 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Tseng $3,578 ($3,578 in general payments such as food, travel and fees) from 26 companies. The largest payer was Pfizer Inc. with $1,701.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 11 | $1,701 |
| Abbvie Inc. ABBV | 16 | $299 |
| Eisai Inc. 4523.T | 8 | $232 |
| Argenx US, Inc. ARGX | 6 | $206 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $156 |
| Lilly USA, LLC LLY | 7 | $155 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $101 |
| Janssen Biotech, Inc. JNJ | 2 | $92 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $83.14 |
| Catalyst Pharmaceuticals, Inc. CPRX | 3 | $59.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.